Adults and adolescents treated with icotrokinra experienced improvements in their moderate to severe plaque psoriasis, ...

Dupilumab is safe and efficacious for the treatment of atopic dermatitis for 3 years among pediatric patients aged 6 months to 11 years.

Patients with rosacea and skin of color are more likely to have severe disease phenotypes when compared with White patients with rosacea.

March 10, 2025) – Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company developing therapeutics ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

The American Academy of Dermatology annual meeting was packed with “massive advancements” across the field, Joel M. Gelfand, ...

American Academy of Dermatology President Seemal R. Desai, MD, FAAD ...

Skin cancer is the most common cancer in the United States and a significant health issue, with millions of non-melanoma ...

Four new officers and four new board members will be installed immediately upon conclusion of the 2025 Annual Meeting of the American Academy of Dermatology. The officers and board members are all ...

Experts stressed the importance of dermatologists engaging in climate advocacy and adopting sustainable practices, as their ...

The following is a summary of “Improved survival at the population level for patients with advanced Merkel cell carcinoma ...